Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829458) titled 'The Use of Remimazolam for TEE' on Sept. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Icahn School of Medicine at Mount Sinai
Condition:
Cardiac Disease
Anesthesia
Intervention:
Drug: Remimazolam
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: September 2026
Target Sample Size: 210
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07829458
Disclaimer: Curated by HT Syndication....